BioAge Labs, Inc. (BIOA) is listed on NASDAQ in Pharmaceutical Stocks. It is $9.67, -4.12%, with a $443.6M market cap. RSI is 30.2, near oversold. Insiders were net buyers across the listed trades.
Technical Analysis
RSI (14) 30.2 Near Oversold
Market Cap $443.6M
Volume 424.4K
Fundamentals — 10-Q Q2 2026
Revenue $5.2M
Net Income $-48.4M
EPS $-1.11
Operating Margin -1047.4%
Net Margin -925.7%
P/E Ratio -8.7x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Barton Shane | Principal Accounting Officer | Sell | 62,566 | $25.20 | $1.6M | 2026 Jun 30 |
| Rubin Paul D | Chief Medical Officer | Sell | 8,820 | $17.81 | $157,084 | 2026 Apr 1 |
| Rubin Paul D | Chief Medical Officer | Sell | 7,433 | $20.30 | $150,890 | 2026 Mar 2 |
| Rubin Paul D | Chief Medical Officer | Sell | 18,000 | $12.00 | $216,000 | 2025 Dec 9 |
| Rubin Paul D | Chief Medical Officer | Sell | 68,897 | $10.19 | $702,060 | 2025 Dec 4 |
| Pande Vijay Satyanand | Director | Buy | 219,195 | $19.75 | $4.3M | 2024 Oct 3 |
| Barton Shane | Principal Accounting Officer | Buy | 2,632 | $18.00 | $47,376 | 2024 Sep 27 |
| Cormorant Private Healthcare Fund V LP | Insider | Buy | 450,000 | $18.00 | $8.1M | 2024 Sep 27 |
| Pande Vijay Satyanand | Director | Buy | 900,000 | $18.00 | $16.2M | 2024 Sep 27 |
| Enright Patrick G | Director | Buy | 400,000 | $18.00 | $7.2M | 2024 Sep 27 |
| Healy James | Director | Buy | 666,665 | $18.00 | $12.0M | 2024 Sep 27 |
| Wall Kenneth W. | Director | Buy | 40,000 | $0.43 | $17,200 | 2017 Nov 30 |
| Hartmann Michael A. | Executive Vice President | Buy | 10,000 | $0.48 | $4,800 | 2017 Aug 18 |
| Millis James | Chief Technology Officer | Buy | 13,333 | $0.00 | $0 | 2017 Aug 15 |
| Haller Heinz | Director | Buy | 40,000 | $0.00 | $0 | 2017 Aug 15 |
| Settino Mario | Chief Financial Officer | Buy | 20,000 | $0.00 | $0 | 2017 Aug 15 |
| Hartmann Michael A. | Executive Vice President | Buy | 13,333 | $0.00 | $0 | 2017 Aug 15 |
| Orecchioni Fabrice | Chief Operations Officer | Buy | 26,666 | $0.00 | $0 | 2017 Aug 15 |
| Richstone Ellen B | Director | Buy | 13,333 | $0.00 | $0 | 2017 Aug 15 |
| Land Raymond J | Director | Buy | 40,000 | $0.00 | $0 | 2017 Aug 15 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
Take BIOA further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put BIOA in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when BioAge Labs, Inc. next reports.
Set alerts on BIOA
Get notified when BioAge Labs, Inc. hits your price targets or technical conditions are met.
Get Started Free